Lu Hongbo Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

ARWR Quotes by TradingView

Lu Hongbo is Director of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 47,163 shares of ARWR, which is worth approximately $917,320. The most recent transaction as insider was on Dec 18, 2024, when has been sold 16,733 shares (Common Stock) at a price of $22.99 per share, resulting in proceeds of $384,691. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.2K
40.03% 3M change
n/a 12M change
Total Value Held $917,320

Lu Hongbo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2024
BUY
Grant, award, or other acquisition
$384,691 $22.99 p/Share
16,733 Added 26.19%
47,163 Common Stock
Mar 20 2024
BUY
Open market or private purchase
$27,500 $27.5 p/Share
1,000 Added 2.88%
33,680 Common Stock
Mar 19 2024
BUY
Open market or private purchase
$28,000 $28.0 p/Share
1,000 Added 2.97%
32,680 Common Stock
Mar 18 2024
BUY
Open market or private purchase
$27,490 $27.49 p/Share
1,000 Added 3.06%
31,680 Common Stock

Also insider at

TPTX
Turning Point Therapeutics, Inc.
Director
TERN
Terns Pharmaceuticals, Inc. Healthcare
Director
ZBIO
Zenas BioPharma, Inc.
Director
Lu Hongbo

Lu Hongbo

Director
San Diego, CA

Track Institutional and Insider Activities on ARWR

Follow ARROWHEAD PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARWR